Cargando…
Amino Acid Polymorphisms Within the Entire HCV NS5A Region in Estonian Chronic HCV 1b Patients With Different Treatment Response
BACKGROUND: A substantial proportion of hepatitis C virus (HCV)-1b infected patients do not response to pegylated interferon-α plus ribavirin (PegIFNα/RBV) combination therapy that was partially associated with mutations in the non-structural 5A (NS5A) protein. OBJECTIVES: Analysis of NS5A polymorph...
Autores principales: | Kuznetsova, Tatiana, Tallo, Tatjana, Brjalin, Vadim, Reshetnjak, Irina, Salupere, Riina, Priimagi, Ljudmilla, Katargina, Olga, Smirnova, Maria, Jansons, Juris, Tefanova, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867023/ https://www.ncbi.nlm.nih.gov/pubmed/24358043 http://dx.doi.org/10.5812/hepatmon.14481 |
Ejemplares similares
-
Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
por: Demetriou, Victoria L, et al.
Publicado: (2010) -
Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent
por: Kwon, Hyock Joo, et al.
Publicado: (2015) -
Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
por: Huik, Kristi, et al.
Publicado: (2014) -
Identification of NS2 determinants stimulating intrinsic HCV NS2 protease activity
por: Isken, Olaf, et al.
Publicado: (2022) -
The Future of HCV Therapy: NS4B as an Antiviral Target
por: Dvory-Sobol, Hadas, et al.
Publicado: (2010)